Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double-blind, Randomized, Placebo-controlled Study of the Safety and Efficacy of SYN115 as Adjunctive Therapy in Levodopa-treated Parkinson's Subjects With End of Dose Wearing Off

NCT01283594 is registered in ClinicalTrials.gov with Biotie Therapies Inc. as lead sponsor.

NCT NCT01283594
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01283594 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double-blind, Randomized, Placebo-controlled Study of the Safety and Efficacy of SYN115 as Adjunctive Therapy in Levodopa-treated Parkinson's Subjects With End of Dose Wearing Off
Lead sponsor
Biotie Therapies Inc.
Phase
Phase 2/3
Overall status
Completed
Start date
March 31, 2011
Completion date
October 31, 2012
Enrollment
420 (actual)
Sites
61

Conditions

As the registry lists them; a condition with its own page is linked.

parkinson's disease